Stocklytics Platform
Asset logo for symbol ANAB
AnaptysBio
ANAB59
$16.14arrow_drop_down2.30%-$0.38
Asset logo for symbol ANAB
ANAB59

$16.14

arrow_drop_down2.30%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

AnaptysBio (ANAB) Stocklytics Forecast

According to market analysts, AnaptysBio Inc (ANAB) is expected to witness a positive trend in its stock price in the coming years. The current stock price prediction for ANAB suggests that it has the potential to experience significant growth. Forecasting models indicate that ANAB stock price will increase steadily, with a positive outlook for the next few years.
The stock price forecast for AnaptysBio Inc (ANAB) in 2023 is also optimistic. Analysts predict that ANAB shares will continue to rise, reflecting the company's positive performance and potential growth prospects. Additionally, AI-based predictions and machine learning algorithms support the notion of ANAB stock experiencing steady growth in the coming years.
add AnaptysBio to watchlist

Keep an eye on AnaptysBio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for AnaptysBio (ANAB) stock?

Analysts have set a target price of $37.39 for AnaptysBio (ANAB), based on forecasts from 23 analysts. The predicted price range extends from a high of $80 to a low of $20. This represents a potential increase of up to 395.66% and a decrease of 23.92% from the current price of $16.14. These forecasts are as of 2021 Feb 11.
help

What are the analyst ratings for AnaptysBio (ANAB) stock?

Currently, there are no analyst ratings available for AnaptysBio (ANAB), possibly due to insufficient coverage or recent updates.
help

What is the AI price prediction for AnaptysBio (ANAB) stock?

At present, there is no AI or machine-learning-based price prediction available for AnaptysBio (ANAB) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level